Accounts Receivable, after Allowance for Credit Loss, Current of Haoxi Health Technology Ltd from 30 Jun 2023 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Haoxi Health Technology Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 30 Jun 2023 to 30 Jun 2025.
Haoxi Health Technology Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Jun 2025 was $460,272, a 103% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Haoxi Health Technology Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$460,272	+$233,525	+103%	30 Jun 2025	20-F	20 Oct 2025	2025	FY
Q4 2024	$734,344			31 Dec 2024	6-K	23 Apr 2025	2025	Q2
Q2 2024	$226,747	+$218,999	+2827%	30 Jun 2024	20-F	20 Oct 2025	2025	FY
Q2 2023	$7,748			30 Jun 2023	20-F	29 Oct 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.